Department of Child Health, Hasan Sadikin General Hospital / Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
Department of Child Health, Hasan Sadikin General Hospital / Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia
Clin Med Res. 2024 Sep;22(3):131-137. doi: 10.3121/cmr.2024.1858.
Few studies of children with long COVID (post-COVID-19 condition) or post-acute sequelae of SARS CoV-2 (PASC) have been reported. Those terms describe symptoms that persist for weeks or months or as new symptoms that develop after SARS-CoV-2 infection. This condition might be found to various degrees in the severity of COVID-19. This study aimed to describe long COVID in confirmed SARS-CoV-2-infected children. An observational cross-sectional study. Tertiary care hospital between January and November 2021. Children, age 5-17 years, with virologically confirmed COVID?19. This study was conducted by completing an electronic form after informed consent was obtained. The subject's characteristics and parent's or guardian's phone numbers were retrieved from the pediatric COVID-19 registry. Parents were contacted to complete a structured electronic questionnaire about the long COVID symptoms noticed in their children. Descriptive statistics were displayed in percentages and median. Parent contact numbers were documented in 125/135 children who fulfilled the study criteria. There were 61 parents (48.8%) who gave consent, while the rest either did not respond or refused. There were 16 children reported as deceased primarily due to chronic renal disease and leukemia. Of the 45 children enrolled, the median (IQR) age was 11 years (5.3-17.6); 51.1% were female; and 75.6% had comorbidities. Two-thirds developed long COVID symptoms, most frequently in the age 5-9 years group, and mostly fatigue (45.2%), decreased appetite (38.7%), and muscle aches (32.3%). All patients with moderate to severe and more than half asymptomatic to mild COVID-19 developed long COVID. Most children had long COVID symptoms similar to adults despite being otherwise asymptomatic or having mild COVID-19.
鲜有关于儿童长新冠(新冠后状况)或 SARS-CoV-2 急性后后遗症(PASC)的研究报告。这些术语描述了持续数周或数月的症状,或在 SARS-CoV-2 感染后出现的新症状。这种情况可能在新冠严重程度的不同程度上发现。本研究旨在描述已确诊 SARS-CoV-2 感染儿童的长新冠。一项观察性横断面研究。2021 年 1 月至 11 月期间在三级保健医院进行。年龄 5-17 岁,经病毒学证实的 COVID-19 儿童。本研究通过在获得知情同意后填写电子表格进行。从儿科 COVID-19 登记册中检索了患儿的特征和父母或监护人的电话号码。与父母联系,让他们填写一份关于其子女注意到的长新冠症状的结构化电子问卷。以百分比和中位数形式展示描述性统计数据。符合研究标准的 135 名儿童中有 125 名的父母联系方式。61 名父母(48.8%)同意,其余的要么没有回应,要么拒绝。有 16 名儿童报告死亡,主要是由于慢性肾病和白血病。在纳入的 45 名儿童中,中位数(IQR)年龄为 11 岁(5.3-17.6);51.1%为女性;75.6%有合并症。三分之二的儿童出现长新冠症状,最常见于 5-9 岁年龄组,最常见的症状是疲劳(45.2%)、食欲不振(38.7%)和肌肉疼痛(32.3%)。所有中重度无症状或轻度 COVID-19 的患儿均出现长新冠。尽管大多数儿童无症状或患有轻度 COVID-19,但他们的长新冠症状与成年人相似。